ALKBH5 and glioblastoma: However, another leukemia cell line, Jurkat, and glioblastoma A-172 cells had low to no susceptibility, suggesting ALKBH5 suppression by small-molecule inhibitors as a feasible cancer-cell-type-selective anti-proliferative approach [162].